Angola vs Marshall Islands: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Angola
62.0%
in 2024
Marshall Islands
62.0%
in 2024
Angola rank
131st
Marshall Islands rank
131st
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Angola
- Marshall Islands
How they compare
Angola currently reports 62.0% against 62.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 6 times across 12 shared years of data; in 2013 it was Marshall Islands ahead.
Angola ranks 131st and Marshall Islands ranks 131st of 146 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Marshall Islands in 1.
Head to head by decade
| Decade | Angola | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.3% | 58.4% | 7.1% | Marshall Islands |
| 2020s | 55.6% | 50.4% | 5.2% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Angola or Marshall Islands?
- Angola, at 62.0% against 62.0% in Marshall Islands as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Angola and Marshall Islands?
- 0.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Marshall Islands?
- 12 years are reported by both, from 2013 to 2024.
- How do Angola and Marshall Islands rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Angola ranks 131st and Marshall Islands ranks 131st of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.